Phase 1 study of KVD818 in healthy volunteers

Trial Profile

Phase 1 study of KVD818 in healthy volunteers

Phase of Trial: Phase I

Latest Information Update: 14 Sep 2017

At a glance

  • Drugs KVD 818 (Primary)
  • Indications Hereditary angioedema
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 14 Sep 2017 According to a KalVista Pharmaceuticals media released, the company is about to complete this trial and plans to evaluate the final data.
    • 01 Sep 2016 New trial record
    • 11 Aug 2016 According to KalVista media release, company announced the dosing of first patient in this trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top